Polpharma to buy 33% stake in Bioton

08/19/2008 | Portfolio.hu (Hungary)

Prokom Investments said it will sell its 33.3% stake in insulin manufacturer Bioton to generic-drug maker Polpharma for about $198 million, with additional milestone payments. Polpharma owner Jerzy Starak said the deal, set to be completed within a month, is a strategic move to biotech products, which he called the future of the pharmaceutical industry.

View Full Article in:

Portfolio.hu (Hungary)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations